Alternatively, if thalidomide results in only a minor or partial inhibition of the production of VEGF, then incorporation of other anti-VEGF drugs into the treatment protocol may help further decrease VEGF production, allowing greater inhibition of cancer growth and metastasis. This evidence concerns the gene VEGFA and cancer.